| 产品详情 |
| Edit |   |
| Product Name | SU 11274 |
| Description | A specific, ATP-competitive small molecule inhibitor of the catalytic activity of Met. Displays selectivity for Met enzyme versus a panel of other tyrosine kinases with the following IC50 values: Met = 0.02 µM, Flk = 1.3 µM, EGFR = >100 µM, PDGFβR = >20 µM, Tie2 = >100 µM, c-src = >10 µM, cdk2 = >10 µM, and FGFR-1 = 9.7 µM). Inhibition of the Met kinase activity by SU11274 leads to time- and dose-dependent reduced cell growth and induced G1 cell cycle arrest and apoptosis. MW: 568.09. Purity ≥98% by HPLC |
| Size | 5 mg |
| Concentration | n/a |
| Applications | n/a |
| Other Names | 3Z)-N-(3-Chlorophenyl)-3-({3,5-dimethyl-4-[(4-methylpiperazin-1-yl)carbonyl]-1H-pyrrol-2-yl}methylene)-N-methyl-2-oxo-2,3-dihydro-1H-indole-5-sulfonamide |
| Gene, Accession, CAS # | CAS: 658084-23-2 |
| Catalog # | 1938-5 |
| Price | |
| Order / More Info | SU 11274 from BIOVISION, INC. |
| Product Specific References | n/a |
| 产品资料 |
|
|